Kailera Therapeutics Inc is a clinical-stage biotechnology company. Kailera Therapeutics (NAS: KLRA) is based in Waltham, MA and was founded in 2024. It is now publicly traded; this page covers its private-market history, where its last recorded valuation was $1.5 billion (Oct 2025). It has raised $1.6 billion.
Last price · $/share
—
Implied valuation
$1.5B
Total raised
$1.6B
Last round
—
Cap table — not yet on record
Kailera Therapeutics (NAS: KLRA)'s share-class structure hasn't surfaced in our sources yet. Cap tables are assembled from certificates of incorporation, round filings, and disclosures as they land.
Pro members can request priority coverage with a 48-hour turnaround.
